abstract |
BACKGROUND OF THE INVENTION The present invention relates to the prime region of the histamine endogenous gene, in particular to its fragments and variants, to nucleic acid-stone constructs containing the prismater, to vectors for the preparation of nucleic acid-stroke cells, and to cells for transfection with aviators. The pharmaceutical compositions containing the necleic acid stone strokes or cells of the present invention are useful in the gene therapy of a number of diseases. ŕ |